Breadcrumb
- Home
- Learning and Research
- What I Learned From The Study of Sex Differences I...
What I Learned From the Study of Sex Differences in Pulmonary Hypertension: How Following the Data and the Kindness of Strangers Helped Me Overcome Self-Doubt and Imposter Syndrome
Tim Lahm
https://doi.org/10.1002/pul2.70189
“Why is there more variation in the females? Could it be due to their estrous cycle?” This was the question my co-mentor, Dr. Irina Petrache, posed when I shared the first data I generated as a first-year research fellow. It was 2007, and was in the lab of cardiothoracic surgeon Dr. Dan Meldrum at Indiana University. Dan studied sex differences in cardiac ischemia-reperfusion injury in the left ventricle. With his model of isolated rat pulmonary artery rings, I joined to explore pulmonary vascular disease. Drawing on Dan′s focus on sex biases in the left ventricle, I compared hypoxic pulmonary vasoconstriction in arteries from male and female rats. After gathering sufficient data, I was disappointed: no statistical difference. Before Dan′s lab meeting, I consulted Irina. Her insight inspired a plan: a well-designed PowerPoint presentation, a literature review on the effects of the oestrous cycle, and experiments on rats of both sexes, along with plans to assess the effects of the oestrous cycle on hypoxic vasoconstriction in pulmonary arteries from female rats. Dan agreed to the study, which found that hypoxic pulmonary vasoconstriction varied with the cycle, attenuating at high estrogen levels. This yielded my first “first-author paper” in the American Journal of Physiology [1]. I was thrilled that I—a working-class German country boy with no experience and who had never held a pipette in his hand - could publish a research paper in this august journal.
Read the full historical vignette
Other materials on this topic
More from Pulmonary Circulation
A collection of up-to-date abstracts from our premier, international, peer-reviewed, medical research journal dedicated exclusively to pulmonary circulation and pulmonary vascular disease.